Exploring the Feasibility of a Bracketing Approach Utilizing Modeling for Development of Long-Acting Injectables for Regulatory Approval—A Case Study Using Levonorgestrel
Background: The development of long-acting products of a characterized drug substance is of great interest. It is possible to support the development of these products with available clinical data by matching the exposure to a predefined bracket of a minimal concentration for efficacy and a maximal...
Saved in:
| Main Authors: | Susan Cole, Henry Pertinez, Andrew S. Butler, Essam Kerwash, Swati Bhat, Eman El-Khateeb, Andrew Owen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/17/12/1640 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quality matters: the role of service quality in discontinuation of long-acting reversible contraceptives in Sub-Saharan Africa; systematic review and meta-analysis
by: Tewachew Muche Liyeh, et al.
Published: (2025-08-01) -
Long-acting reversible hormonal contraception
by: N. E. Dahan-Farkas, et al.
Published: (2016-11-01) -
The use, knowledge and attitudes regarding hormonal contraceptive products of female first-year students in a Faculty of Health Sciences
by: P. M. van Zyl, et al.
Published: (2019-10-01) -
Long-acting reversible methods of contraception: trends, levels, and predictors among married women of reproductive age in Nigeria
by: Joseph Ayodeji Kupoluyi
Published: (2025-08-01) -
Contraceptive uptake and compliance after structured contraceptive counseling ‐ secondary outcomes of the LOWE trial
by: Isabella Bizjak, et al.
Published: (2024-05-01)